In a recent study, Hondelink et al. developed a fully supervised DL model for PD-L1 TPS assessment in NSCLC WSIs according to three cut-off points (<1%, 1–50%, and 50–100%) [110]. Here, CD274 is linked to non-small cell lung carcinoma.